Korea Otsuka Pharmaceutical Co., Ltd.
Pletaal SR Post Marketing Observational Study
- Conditions
- Ischemic SymptomsCerebral Infarction
- First Posted Date
- 2013-02-04
- Last Posted Date
- 2019-03-01
- Lead Sponsor
- Korea Otsuka Pharmaceutical Co., Ltd.
- Target Recruit Count
- 3635
- Registration Number
- NCT01782833
- Locations
- ๐ฐ๐ท
Kyungpook National University Hospital, Daegu, Korea, Republic of
๐ฐ๐ทNHIC Ilsan Hospital, Goyang, Korea, Republic of
๐ฐ๐ทInje University Seoul Pail Hospital, Seoul, Korea, Republic of
Efficacy and Safety Study of Probucol in Patients With Diabetic Nephropathy
- Conditions
- Diabetic Nephropathy
- Interventions
- First Posted Date
- 2012-11-15
- Last Posted Date
- 2017-05-03
- Lead Sponsor
- Korea Otsuka Pharmaceutical Co., Ltd.
- Target Recruit Count
- 126
- Registration Number
- NCT01726816
- Locations
- ๐ฐ๐ท
The Catholic university of Korea, Bucheon St. Mary's Hospital, Bucheon, Korea, Republic of
๐ฐ๐ทKyungpook National University, DaeGu, Korea, Republic of
๐ฐ๐ทYeungnam University Medical Center, DaeGu, Korea, Republic of
A Study to Evaluate the Efficacy and Safety of Pletaal SR Capsule (Cilostazol) in Subjects With Peripheral Arterial Disease Symptom Due to Chronic Occlusive Arterial Disease
- Conditions
- Chronic Occlusive Arterial Disease
- Interventions
- Drug: Pletaal SR capsule
- First Posted Date
- 2012-10-22
- Last Posted Date
- 2022-06-10
- Lead Sponsor
- Korea Otsuka Pharmaceutical Co., Ltd.
- Target Recruit Count
- 101
- Registration Number
- NCT01711333
- Locations
- ๐ฐ๐ท
KYUNG-HEE UNIVERSITY HOSPITAL at GANGDONG, Seoul, Korea, Republic of
Effect of Samsca on Control of Hyponatremia and Extracellular Fluid in Cirrhotic Patients With Ascites
- Conditions
- Hyponatremia and Extracellular Fluid in Cirrhotic
- Interventions
- Drug: Placebo
- First Posted Date
- 2012-03-13
- Last Posted Date
- 2022-03-04
- Lead Sponsor
- Korea Otsuka Pharmaceutical Co., Ltd.
- Target Recruit Count
- 74
- Registration Number
- NCT01552590
- Locations
- ๐ฐ๐ท
Hallym Univ. Chuncheon Sacred Heart Hospital, Bucheon, Korea, Republic of
๐ฐ๐ทSoonchunhyang Univ. Bucheon Hospital, Bucheon, Korea, Republic of
๐ฐ๐ทWonju Christian Hospital, Wonju, Korea, Republic of
Evaluate the Efficacy and Safety of Pletaal (Cilostazol) in Subjects With Vasospastic Angina
- Conditions
- Variant Angina
- Interventions
- Drug: Placebo
- First Posted Date
- 2011-10-03
- Last Posted Date
- 2012-07-16
- Lead Sponsor
- Korea Otsuka Pharmaceutical Co., Ltd.
- Target Recruit Count
- 50
- Registration Number
- NCT01444885
- Locations
- ๐ฐ๐ท
Keimyung University Dongsan Medical Center, Daegu, Korea, Republic of
๐ฐ๐ทChungNam Univ. Hospital, DaeJeon, Korea, Republic of
๐ฐ๐ทGangneung Asan Hospital, Gangneung, Korea, Republic of
Open-label, Extension Study of CDP870 in Patients With Rheumatoid Arthritis
- First Posted Date
- 2010-09-09
- Last Posted Date
- 2022-06-10
- Lead Sponsor
- Korea Otsuka Pharmaceutical Co., Ltd.
- Target Recruit Count
- 110
- Registration Number
- NCT01197066
Evaluation of Concomitant Administration of Cilostazol and Probucol on Biomarkers, Endothelial Function and Safety
- First Posted Date
- 2010-06-11
- Last Posted Date
- 2022-07-18
- Lead Sponsor
- Korea Otsuka Pharmaceutical Co., Ltd.
- Target Recruit Count
- 80
- Registration Number
- NCT01142284
- Locations
- ๐ฐ๐ท
Asan Medical Center, Seoul, Korea, Republic of
Pharmacokinetics/Pharmacodynamics (PK/PD) Characteristics of Tolvaptan Tablet in Korean Healthy Male
- First Posted Date
- 2009-11-17
- Last Posted Date
- 2010-03-11
- Lead Sponsor
- Korea Otsuka Pharmaceutical Co., Ltd.
- Target Recruit Count
- 46
- Registration Number
- NCT01014416
- Locations
- ๐ฐ๐ท
Seoul National University Hospital, Seoul, Korea, Republic of
Pharmacokinetics Study for Probucol
- First Posted Date
- 2009-10-23
- Last Posted Date
- 2022-03-04
- Lead Sponsor
- Korea Otsuka Pharmaceutical Co., Ltd.
- Target Recruit Count
- 30
- Registration Number
- NCT01000467
- Locations
- ๐ฐ๐ท
Seoul national univeristy, Seoul, Korea, Republic of
A Study of CDP870 as Add-on Meditation to Methotrexate (MTX) in Patients With Rheumatoid Arthritis
- Conditions
- Rheumatoid Arthritis
- Interventions
- First Posted Date
- 2009-10-12
- Last Posted Date
- 2012-09-27
- Lead Sponsor
- Korea Otsuka Pharmaceutical Co., Ltd.
- Target Recruit Count
- 127
- Registration Number
- NCT00993317
- Locations
- ๐ฐ๐ท
Kyungpook National University Hospital, Daegu, Korea, Republic of
๐ฐ๐ทCatholic University Hospital of Daegu, Daegu, Korea, Republic of
๐ฐ๐ทEulji University Hospital, Daejeon, Korea, Republic of